Endeavor

Moffitt’s Top Stories of 2025

Let’s rewind and revisit the cancer center’s top highlights of the year

A Popular Sunscreen Ingredient Used in Europe Could Be Coming to the US

Bemotrizinol has proved safe and effective and may be available by the end of 2026

Expert Shares How Better Conversations Lead to Better Care

John Daly, PhD, shares small shifts that change communication in health care

New Cervical Cancer Screening Guidelines Include At-Home Test

The FDA approved a self-collection kit in May for those at average risk

Highlighting Moffitt’s Top Research Stories of 2025

Breakthrough discoveries that shaped cancer science in 2025

Environmental Services Team Achieves Certification Milestone

Members refine skills in infection control, waste management and patient safety

How AI Is Helping To Improve Diagnosing Bone Marrow Disorders

AI could offer a clearer and more consistent way of distinguishing early bone marrow problems from myelodysplastic syndrome

New Treatment Approach Could Redefine Standard Chemotherapy for Acute Myeloid Leukemia

Study finds azacitidine and venetoclax may match or outperform standard chemotherapy for newly diagnosed patients

Patients Move for a Purpose During First Inpatient Miles for Moffitt Event

Around 40 volunteers and dozens of patients participated in the event